
Normal Laboratory Values and Ranges For MRCP Question Papers
Date: Monday, July 07 @ 04:27:45 IST Topic: MRCP Part 1
Print this page
Haematology
Full blood count
Haemoglobin (males) 13.0 – 18.0 g/dL
Haemoglobin (females) 11.5 – 16.5 g/dL
Haematocrit (males) 0.40 – 0.52
Haematocrit (females) 0.36 – 0.47
MCV 80 – 96 fL
MCH 28 – 32 pg
MCHC 32 – 35 g/dL
White cell count 4 – 11 x 109/L
White cell differential:
Neutrophils 1.5 – 7 x 109/L
Lymphocytes 1.5 – 4 x 109/L
Monocytes 0 – 0.8 x 109/L
Eosinophils 0.04 – 0.4 x 109/L
Basophils 0 – 0.1 x 109/L
Platelet count 150 – 400 x 109/L
Reticulocyte count 25 – 85 x 109/L
OR 0.5 – 2.4%
Erythrocyte sedimentation rate
Westergren
Under 50 years:
Males 0 – 15 mm/1st hr
Females 0 – 20 mm/1st hr
Over 50 years:
Males 0 – 20 mm/1st hr
Females 0 – 30 mm/1st hr
Plasma viscosity (25°C) 1.50 – 1.72 mPa/s
Coagulation Screen
Prothrombin time 11.5 – 15.5s
International normalised ratio <1.4
Activated partial thromboplastin time 30 – 40s
Fibrinogen 1.8 – 5.4 g/L
Bleeding time 3 – 8m
Coagulation Factors
Factors II, V, VII, VIII, IX, X, XI, XII 50 – 150 IU/dL
Factor V Leiden
Von Willebrand factor 45 – 150 IU/dL
Von Willebrand factor antigen 50 – 150 IU/dL
Protein C 80 – 135 IU/dL
Protein S 80 – 120 IU/dL
Antithrombin III 80 – 120 IU/dL
Activated protein C resistance 2.12 – 4.0
Fibrin degradation products < 100 mg/L
D-Dimer screen < 0.5 mg/L
Haematinics
Serum iron 12 – 30 µmol/L
Serum iron-binding capacity 45 – 75 µmol/L
Serum ferritin 15 – 300 µg/L
Serum transferrin 2.0 – 4.0 g/L
Serum B12 160 – 760 ng/L
Serum folate 2.0 – 11.0µg/L
Red cell folate 160 – 640 µg/L
Serum haptoglobin 0.13 – 1.63 g/L
Haemoglobin electrophoresis:
Haemoglobin A > 95%
Haemoglobin A2 2 – 3%
Haemoglobin F < 2 %
Chemistry
Serum sodium 137 – 144 mmol/L
Serum potassium 3.5 – 4.9 mmol/L
Serum chloride 95 – 107 mmol/L
Serum bicarbonate 20 – 28 mmol/L
Anion gap 12 – 16 mmol/L
Serum urea 2.5 – 7.5 mmol/L
Serum creatinine 60 – 110 µmol/L
Serum corrected calcium 2.2 – 2.6 mmol/L
Serum phosphate 0.8 – 1.4 mmol/L
Serum total protein 61 – 76 g/L
Serum albumin 37 – 49 g/L
Serum total bilirubin 1 – 22 µmol/L
Serum conjugated bilirubin 0 – 3.4 µmol/L
Serum alanine aminotransferase 5 – 35 U/L
Serum aspartate aminotransferase 1 – 31 U/L
Serum alkaline phosphatase 45 – 105 U/L (over 14 years)
Serum gamma glutamyl transferase 4 – 35 U/L (< 50 U/L in males)
Serum lactate dehydrogenase 10 – 250 U/L
Serum creatine kinase (Males) 24 – 195 U/L
Serum creatine kinase (Females) 24 – 170 U/L
Creatine kinase MB fraction < 5%
Serum troponin I 0-0.4 µg/L
Serum troponin T 0 – 0.1 µg/L
Serum copper 12 – 26 µmol/L
Serum caeruloplasmin 200 – 350 mg/L
Serum aluminium 0-10 µg/L
Serum magnesium 0.75 – 1.05 mmol/L
Serum zinc 6 – 25 µmol/L
Serum urate (males) 0.23 – 0.46 mmol/L
Serum urate (females) 0.19 – 0.36 mmol/L
Plasma lactate 0.6 – 1.8 mmol/L
Plasma ammonia 12 – 55 µmol/L
Serum angiotensin-converting enzyme 25 – 82 U/L
Fasting plasma glucose 3.0 – 6.0 mmol/L
Haemoglobin A1 C 3.8 – 6.4%
Fructosamine < 285 µmo/L
Serum amylase 60 – 180 U/L
Plasma osmolality 278 – 305 mosmol/Kg
Urine
Albumin/creatinine ratio (untimed specimen) <3.5 mg/mmol (males)
<2.5 mg/mmol (females)
Lipids and Lipoproteins
The target levels will vary depending on the patient’s overall cardiovascular risk assessment.
Serum cholesterol: < 5.2 mmol/L
Serum LDL cholesterol: < 3.36 mmol/L
Serum HDL cholesterol: > 1.55 mmol/L
Fasting serum triglyceride 0.45 – 1.69 mmol/L
Blood Gases (breathing air at sea level)
Blood H+ 35 – 45 nmol/L
pH 7.36 – 7.44
PaO2 11.3 – 12.6 kPa
PaCO2 4.7 – 6.0 kPa
Base excess ± 2 mmol/L
Carboxyhaemoglobin:
Non-smoker < 2%
Smoker 3 – 15%
Endocrinology
Adrenal steroids
Blood
Serum aldosterone (normal diet)
Upright (4h) 330 – 830 pmol/L
Supine (30m) 135 – 400 pmol/L
Serum cortisol:
09.00h 200 – 700 nmol/L
22.00h 50 – 250 nmol/L
Overnight dexamethasone suppression test (after 1mg dexamethasone)
Serum cortisol < 50 nmol/l
Low dose dexamethasone suppression test (2 mg/day for 48h)
Serum cortisol < 50 nmol/L
After insulin-induced hypoglycaemia (blood glucose < 2.2 mmol/L)
Serum cortisol > 550 nmol/L and 200 nmol/L greater than
baseline
Plasma 11 – deoxycortisol 24 – 46 nmol/L
Serum dehydroepiandrosterone
(09.00) 7 – 31 nmol/L
Serum dehydroepiandrosterone sulphate:
(Males) 2 – 10 µmol/L
(Females) 3 – 12 µmol/L
Serum androstenedione (adults)
Males 1.6 – 8.4 nmol/L
Females 0.6 – 8.8 nmol/L
Post menopausal females 0.9 – 6.8 nmol/L
Serum 17-hydroxyprogesterone:
Males 1 – 10 nmol/L
Females
Follicular 1 – 10 nmol/L
Luteal 10 – 20 nmol/L
Serum oestradiol
Males < 180 pmol/L
Females
Post-menopausal < 100 pmol/L
Follicular 200 – 400 pmol/L
Mid-cycle 400 – 1200 pmol/L
Luteal 400 – 1000 pmol/L
Serum progesterone
Males < 6 nmol/L
Females
Follicular < 10 nmol/L
Luteal > 30 nmol/L
Serum testosterone
Males 9 – 35 nmol/L
Females 0.5 – 3 nmol/L
Serum dihydrotestosterone
Males 1- 2.6 nmol/L
Females 0.3 – 9.3 nmol/L
Serum sex hormone binding protein
Males 10 – 62 nmol/L
Females 40 – 137 nmol/L
Urine
Aldosterone 14 – 53 nmol/24h
Cortisol 55 – 250 nmol/24h
Plasma angiotensin II 5 – 35 pmol/L
Plasma renin activity
Recumbent 1.1 – 2.7 pmol/ml/h
Erect after 30m 3.0 – 4.3 pmol/ml/h
Pancreatic and gut hormones
Plasma gastrin < 55 pmol/L
Plasma or serum insulin:
Overnight fasting < 186 pmol/L
After hypoglycaemia
(Blood glucose < 2.2 mmol/L) < 21 pmol/L
Plasma vasoactive intestinal polypeptide < 30 pmol/L
Plasma pancreatic polypeptide < 300 pmol/L
Plasma glucagon < 50 pmol/L
Anterior pituitary hormones
Plasma adrenocorticotrophic hormone
09.00 < 18 pmol/L
Plasma follicle stimulating hormone
Males 1 – 7 U/L
Females
Follicular 2.5 – 10 U/L
Midcycle 25 – 70 U/L
Luteal 0.32 – 2.1 U/L
Post-menopausal > 30 U/L
Plasma growth hormone
Basal, fasting and between pulses < 1 mU/L
After hypoglycaemia > 40 mU/L
Plasma luteinizing hormone
Males 1 – 10 U/L
Females
Follicular 2.5 – 10 U/L
Midcycle 25 – 70 U/L
Luteal 1 – 13 U/L
Post-menopausal > 30 U/L
Plasma prolactin < 360 mU/L
Plasma thyroid stimulating hormone 0.4 – 5 mU/L
Posterior pituitary hormones
Plasma antidiuretic hormone 0.9 – 4.6 pmol/L
Thyroid hormones
Plasma thyroid binding globulin 13 – 28 mg/L
Plasma thyroxine (T4) 58 – 174 nmol/L
Free T4 10 – 22 pmol/L
Tri-iodothyronine (T3) 1.07 – 3.18 nmol/L
Free T3 5 – 10 pmol/L
Serum TSH receptor antibodies < 7 U/L
Serum antithyroid peroxidase < 50 IU/mL
Serum thyroid receptor antibodies < 10 U/L
Catecholamines
(Plasma recumbent with venous catheter in place for 30m prior to collection of sample)
Adrenaline 0.03 – 1.31 nmol/L
Noradrenaline 0.47 – 4.14 nmol/L
Urine
Vanillyl mandelic acid 5 – 35 µmol/24h
Dopamine < 3100 nmol/24h
Adrenaline < 144 nmol/24h
Noradrenaline < 570 nmol/24h
Hydroxyindole acetic acid < 70 µmol/24h
Others
Plasma parathyroid hormone 0.9 – 5.4 pmol/L
Plasma calcitonin < 27 pmol/L
Serum cholecalciferol (vitamin D3) 60 – 105 nmol/L
Serum 25 – OH – cholecalciferol 45 – 90 nmol/L
Age-related insulin like growth factor – 1
13 – 15 yrs 9.3 – 56.0 nmol/L
16 – 18 yrs 9.3 – 56.0 nmol/L
20 – 40 yrs 7.5 – 37.3 nmol/L
40 – 60 yrs 5.6 – 23.3 nmol/L
>60 yrs 3.3 – 23.3 nmol/L
Immunology / Rheumatology
Complement C3 65 – 190 mg/dL
Complement C4 15 – 50 mg/dL
Total haemolytic (CH50) 150 – 250 U/L
Serum C-reactive protein < 10 mg/L
Serum immunoglobins
IgG 6.0 – 13.0 g/L
IgA 0.8 – 3.0 g/L
IgM 0.4 – 2.5 g/L
IgE <120 kU/L
Serum β2 – micro globulin < 3 mg/L
Autoantibodies (all serum)
Adrenal Negative at 1:10 Dil.
Anticentromere antibodies Negative at 1:40 Dil.
Anticardiolipin antibody
IgG 0 – 23
IgM 0 - 11
Anti double-stranded DNA (ELISA) 0 – 73 U/mL
Antineutrophil cytoplasmic antibodies
Anti Proteinase 3 Negative
Anti MPO Negative
Antinuclear antibodies Negative at 1:20 Dil.
ENA Negative
Gastric parietal cells Negative at 1:20 Dil.
Interstitial cells of testis Negative at 1:10 Dil.
Jo-1 Negative
La Negative
Mitochondrial Negative at 1:20 Dil.
RNP Negative
Scl-70 Negative
Ro Negative
Skeletal muscle Negative at 1:60 Dil.
Sm Negative
Smooth muscle Negative at 1:20 Dil.
Thyroid colloid and microcosmal antigens Negative at 1:10 Dil.
Rheumatoid factor < 30 k IU/L
Tumour Markers
Serum alpha-fetoprotein <10 kU/L
Serum carcinoembryonic antigen < 10 µg/L
Serum neurone specific enolase < 12 µg/L
Serum prostate specific antigen
Males over 40 <4 µg/L
Males under 40 <2 µg/L
Serum human chorionic gonadotrophin < 5 U/L
Serum CA 125 < 35 U/mL
Serum CA 19 – 9 < 33 U/mL
Therapeutic Drug Levels
Plasma aminophylline 10 – 20 µg/mL
Plasma carbamazepine 34 – 51 µmol/L
Blood ciclosporin 100 – 150 nmol/L
Plasma digoxin (taken at least 6h post dose) 1 – 2 nmol/L
Plasma ethosuximide 280 – 710 µmol/L
Blood gentamicin (peak) 5 – 7 µg/ml
Serum lithium 0.5 – 1.5 mmol/L
Serum phenobarbital 65 – 172 µmol/L
Serum phenytoin 40 – 80 µmol/L
Serum primidone 23 – 55 µmol/L
Plasma theophylline 55 – 110 µmol/L
Cerebro-spinal fluid
Opening pressure 50 – 180 mm H2O
Total protein 0.15 – 0.45 g/L
Albumin 0.066 – 0.442 g/L
Chloride 116 – 122 mmol/L
Glucose 3.3 – 4.4 mmol/L
Lactate 1 –2 mmol/L
Cell count ≤ 5 mL-1
Differential:
Lymphocytes 60 – 70%
Monocytes 30 – 50%
Neutrophils None
IgG/ALB ≤ 0.26
IgG index ≤ 0.88
Urine
Glomerular filtration rate 70 – 140 mL/min
Total protein < 0.2g/24h
Albumin < 30 mg/24 h
Calcium 2.5 – 7.5 mmol/24h
Urobilinogen 1.7 – 5.9 µmol/24h
Coproporphyrin < 300 nmol/24h
Uroporphyrin 6 – 24 nmol/24h
Delta-aminolevulinate 8 – 53 µmol/24h
5-hydroxyindoleacetic acid 10 – 47 µmol/24h
Osmolality 350 – 1000 mosmol/Kg
Faeces
Nitrogen 70 – 140 mmol/24h
Urobilinogen 50 – 500 µmol/24h
Coproporphyrin 0.018 – 1.2 µmol/24h
Coproporphyrin 0.46 mmol/g dry weight
Protoporphyrin 0 – 4 µmol/24h
Protoporphyrin 0 – 220 nmol/g dry weight
Total porphyrin
(ether soluble) 10 – 200 nmol/g dry weight
(ether insoluble) 0 – 24 nmol/g dry weight
Fat (on normal diet) < 7g / 24h
|
|